DGX Quest Diagnostics Incorporated Common Stock
$240.04
株価 · 8月 19, 2026
ファンダメンタルズ（時点） 7月 23, 2026
52週レンジ
$171–$242
97% of range
アナリスト評価
HOLD
23 analysts
目標株価
$246
+2% upside
P/E (TTM)
27.7
ROE
14.2%
純利益率
9.0%
Quest Diagnostics Incorporated Common Stock について Wikipediaからの企業概要
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
続きを読む
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
As of 2020, the company had approximately 48,000 employees, and it generated more than $7.7 billion in revenue in 2019. The company offers access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders, COVID-19, and employment and court-ordered drug testing.
History
1960–1995
Originally founded as Metropolitan Pathology Laboratory, Inc. in 1967 by Paul A. Brown, MD, the clinical laboratory underwent a variety of name changes. In 1969, the company's name changed to MetPath, Inc. with headquarters in Teaneck, New Jersey. By 1982, MetPath was acquired by what was then known as Corning Glass Works and was subsequently renamed Corning Clinical Laboratories.
1996–2000
On December 31, 1996, Quest Diagnostics became an independent company as a spin-off from Corning. Kenneth W. Freeman was appointed as CEO during this transition. Over the next year, Quest acquired a clinical laboratory division of Branford, Connecticut–based Diagnostic Medical Laboratory, Inc. (DML). Two years later in 1999, Quest added SmithKline Beecham Clinical Laboratories to their subsidiaries; which includes a joint venture ownership with CompuNet Clinical Laboratory. The purchase of SmithKline Beecham also included the lab's medical sample transport airline (ICAO: LBQ, call sign: LABQUEST) originally founded in 1988.
In 1997, Quest and Banner Health formed a joint venture creating the Arizona based Sonora Quest laboratory, a business unit of Laboratory Sciences of Arizona. This entity represents the operations of Quest Diagnostics in the Arizona regional market.
2001–2015
From May 2004 to April 2012, Surya Mohapatra served as the company's President and CEO. In 2007 Quest acquired diagnostic testing equipment company AmeriPath. In response to Mohapatra's resignation after eight years with Quest, former Philips Healthcare CEO Stephen Rusckowski was appointed. Under Rusckowski, Quest Diagnostics teamed up with central New England's largest health care system, UMass Memorial Health Care, to purchase its clinical outreach laboratory.
2016–present
In 2016, Quest collaborated with Safeway to bring testing services to twelve of its stores in California, Maryland, Virginia, Texas and Colorado.
By the end of 2017, Quest, in partnership with Walmart, incorporated laboratory testing in about 15 of their locations in Texas and Florida.
In May 2018, the company announced it will become an in-network laboratory provider to UnitedHealthcare starting in 2019, providing access to 48 million plan members.
In September 2018, Quest moved its headquarters from Madison, where it was located since 2007, to Secaucus, New Jersey.
In November 2018, Quest launched QuestDirect, a consumer-initiated testing service that allows patients to order health and wellness lab testing from home.
In March 2020, the company launched a COVID-19 testing service. As of July 2020, Quest had performed more than 9.2 million COVID-19 molecular tests and 2.8 million serology tests.
In April 2024, Quest has added a new blood screening to their AD-Detect product line. This test will analyze the blood for a specific Alzheimer's protein, pTau-217.
In February 2025, Quest acquired select assets of Fresenius Medical Care's Spectra laboratories. Under a separate agreement, Quest now offers clinical testing and lab services related to dialysis and end-stage kidney disease.
Acquisitions
Partnerships
2005: Forms a strategic alliance with Ciphergen Biosystems to commercialize novel proteomic tests.
Controversies
Quest Diagnostics set a record in April 2009 when it paid $302 million to the government to settle a Medicare fraud case alleging the company sold faulty medical testing kits. It was the largest qui tam (whistleblower) settlement paid by a medical laboratory for manufacturing and distributing a faulty product. In May 2011, Quest paid $241 million to the state of California to settle a False Claims Act case that alleged the company had overcharged Medi-Cal, the state's Medicaid program, and provided illegal kickbacks as incentives for healthcare providers to use Quest labs.
In 2018, Quest Diagnostics was among a number of U.S.–based laboratories linked to inaccuracies of over 200 women's cervical smear tests for CervicalCheck, Ireland's national screening program. Audits of the testing performed by Quest (and another subcontractor, Clinical Pathology Laboratories, Inc. of Austin, Texas) showed a high rate of errors in analysis of samples which led to lawsuits and a government inquiry. Quest and the Irish government continue to settle the resulting lawsuits.
On June 3, 2019, Quest announced that American Medical Collection Agency (AMCA), a billing collections service provider, had informed Quest Diagnostics that an unauthorized user had access to AMCA’s system containing personal information AMCA received from various entities, including from Quest. AMCA provides billing collections services to Optum360, which in turn is a Quest contractor. AMCA later went bankrupt after the breach.
出典: Wikipedia (英語), CC BY-SA 4.0 · Wikipediaで表示 ↗
DGX 株価スナップショット 価格、時価総額、P/E、EPS、ROE、負債/資本、52週レンジ
株価
$240.04
時価総額
$26.64B
P/E (TTM)
27.7
EPS（TTM）
$8.75
収益（TTM）
$11.04B
配当利回り
1.3%
ROE
14.2%
負債/自己資本
0.8
52週レンジ
$171 – $242
DGX 株価チャート 技術指標付きの日次 OHLCV — パン、ズーム、ビューのカスタマイズ
Configure
10年間のパフォーマンス 収益、純利益、利益率、EPSのトレンド
収益と純利益
$11.04B
2016-12-31
→
2025-12-31
EPS
$8.75
2016-12-31
→
2025-12-31
フリーキャッシュフロー
$1.36B
2016-12-31
→
2025-12-31
利益率
9.0%
2016-12-31
→
2020-12-31
バリュエーション P/E、P/S、P/B、EV/EBITDA比率 — 株は割高か割安か？
指標
5年トレンド
DGX
競合中央値
P/E (TTM)
27.7
26.5
P/S (TTM) (株価売上高倍率（TTM）)
2.4
2.0
P/B (株価純資産倍率)
3.7
4.9
EV / EBITDA (EV/EBITDA)
15.0
—
Price / FCF (株価FCF倍率)
19.6
—
収益性 粗利益率、営業利益率、純利益率、ROE、ROA、ROIC
指標
5年トレンド
DGX
競合中央値
Operating Margin (営業利益率)
14.1%
—
Net Profit Margin (純利益率)
9.0%
4.0%
ROA
6.1%
5.0%
ROE
14.2%
15.2%
ROIC
9.2%
—
財務健全性 負債、流動性、支払能力 — バランスシートの健全性
指標
5年トレンド
DGX
競合中央値
Debt / Equity (負債資本倍率)
0.8
—
Current Ratio (流動比率)
1.0
1.6
Quick Ratio (クイックレシオ)
0.8
—
成長 収益、EPS、純利益の成長率：前年比、3年CAGR、5年CAGR
指標
5年トレンド
DGX
競合中央値
Revenue YoY (収益（前年比）)
11.8%
—
Revenue CAGR 3Y (収益（3年CAGR）)
3.7%
—
Revenue CAGR 5Y (収益（5年CAGR）)
3.2%
—
EPS YoY
13.8%
—
Net Income YoY (純利益（前年比）)
13.9%
—
資本効率 総資産回転率、棚卸資産回転率、売掛金回転率
指標
5年トレンド
DGX
競合中央値
Payout Ratio (配当性向)
35.6%
—
配当金 利回り、配当性向、配当履歴、5年CAGR
配当利回り
1.3%
配当性向
35.6%
5年配当CAGR
—
| 権利落ち日 | 金額 |
|---|---|
| 2026年7月8日 | $0.8600 |
| 2026年4月6日 | $0.8600 |
| 2026年1月13日 | $0.8000 |
| 2025年10月3日 | $0.8000 |
| 2025年7月7日 | $0.8000 |
| 2025年4月7日 | $0.8000 |
| 2025年1月14日 | $0.7500 |
| 2024年10月4日 | $0.7500 |
| 2024年7月8日 | $0.7500 |
| 2024年4月5日 | $0.7500 |
| 2024年1月16日 | $0.7100 |
| 2023年10月5日 | $0.7100 |
| 2023年7月10日 | $0.7100 |
| 2023年4月6日 | $0.7100 |
| 2023年1月17日 | $0.6600 |
| 2022年10月3日 | $0.6600 |
| 2022年7月5日 | $0.6600 |
| 2022年4月5日 | $0.6600 |
| 2022年1月18日 | $0.6200 |
| 2021年10月4日 | $0.6200 |
DGX アナリストコンセンサス 強気・弱気のアナリストの見解、12ヶ月の目標株価、アップサイド
買い
23 アナリスト
- 強い買い 6 26.1%
- 買い 7 30.4%
- 保有 10 43.5%
- 売り 0 0.0%
- 強い売り 0 0.0%
12ヶ月目標株価
15 アナリスト · 2026-08-16
中央値
$250.00
現在
$240.04
安値
$204.00
高値
$265.00
中央値ターゲット
$250.00
+4.1%
平均値ターゲット
$245.87
+2.4%
決算履歴 EPS実績 vs 予想、サプライズ%、達成率、次回決算日
平均サプライズ
0.09%
| 期間 | EPS Actual | EPS 予想 | サプライズ |
|---|---|---|---|
| 2026年6月30日 | $3.12 | $2.85 | 0.27% |
| 2026年3月31日 | $2.50 | $2.37 | 0.13% |
| 2025年12月31日 | $2.42 | $2.38 | 0.04% |
| 2025年9月30日 | $2.60 | $2.53 | 0.07% |
| 2025年6月30日 | $2.62 | $2.60 | 0.02% |
| 2025年3月31日 | $2.21 | $2.17 | 0.04% |
同業他社比較（GICSサブインダストリー） 主要メトリクスとセクターピアの比較
| ティッカー | 時価総額 | P/E | 売上高 YoY | 純利益率 | ROE | 粗利益率 |
|---|---|---|---|---|---|---|
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | — |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
| CI | $72.51B | 12.4 | 11.2% | 2.2% | 14.4% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | — |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| CHE | — | 23.3 | 4.1% | 10.5% | 24.4% | — |
| HIMS | — | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
完全なファンダメンタルズ 年次別全指標 — 損益計算書、貸借対照表、キャッシュフロー
損益計算書 17
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.04B | $9.87B | $9.25B | $9.88B | $10.79B | $9.44B | $7.73B | $7.53B | $7.40B | $7.21B | $7.49B | $7.43B | |
| Cost of Revenue | $7.37B | $6.63B | $6.20B | $6.45B | $6.58B | $5.80B | $5.04B | $4.93B | $4.72B | $4.62B | $4.66B | $4.64B | |
| Gross Profit | · | · | · | · | · | $3.63B | $2.69B | $2.60B | $2.68B | $2.90B | $2.84B | $2.80B | |
| SG&A Expense | $1.97B | $1.77B | $1.64B | $1.87B | $1.73B | $1.55B | $1.46B | $1.42B | $1.44B | $1.38B | $1.68B | $1.73B | |
| Operating Expenses | $9.48B | $8.53B | $7.99B | $8.46B | $8.41B | $7.47B | $6.50B | $6.43B | $6.24B | $5.94B | $6.09B | $6.45B | |
| Operating Income | $1.56B | $1.35B | $1.26B | $1.43B | $2.38B | $1.97B | $1.23B | $1.10B | $1.17B | $1.28B | $1.40B | $983M | |
| Interest Expense | · | · | $163M | $148M | $152M | $166M | $180M | $169M | $153M | $144M | $154M | $167M | |
| Interest Income | $13M | $25M | $11M | $10M | $1M | $3M | $5M | $2M | $2M | $1M | $1M | $3M | |
| Other Non-op | $26M | $30M | $20M | $-55M | $369M | $76M | $20M | $-8M | $16M | $-48M | $-143M | $4M | |
| Pretax Income | $1.32B | $1.18B | $1.13B | $1.24B | $2.60B | $1.88B | $1.08B | $926M | $1.03B | $1.09B | $1.10B | $823M | |
| Income Tax | $314M | $273M | $248M | $264M | $597M | $460M | $247M | $182M | $241M | $429M | $373M | $262M | |
| Net Income | $992M | $871M | $854M | $946M | $2.00B | $1.43B | $858M | $736M | $772M | $645M | $709M | $556M | |
| EPS (Basic) | $8.87 | $7.78 | $7.59 | $8.10 | $15.85 | $10.62 | $6.36 | $5.39 | $5.63 | $4.58 | $4.92 | $3.83 | |
| EPS (Diluted) | $8.75 | $7.69 | $7.49 | $7.97 | $15.55 | $10.47 | $6.28 | $5.29 | $5.50 | $4.51 | $4.87 | $3.81 | |
| Shares (Basic) | 111,000,000 | 111,000,000 | 112,000,000 | 116,000,000 | 125,000,000 | 134,000,000 | 134,000,000 | 136,000,000 | 137,000,000 | 140,000,000 | 144,000,000 | 145,000,000 | |
| Shares (Diluted) | 113,000,000 | 113,000,000 | 113,000,000 | 118,000,000 | 128,000,000 | 136,000,000 | 136,000,000 | 139,000,000 | 140,000,000 | 142,000,000 | 145,000,000 | 145,000,000 | |
| EBITDA | $2.13B | $1.84B | $1.70B | $1.86B | $2.79B | $2.33B | $1.56B | $1.41B | $1.44B | $1.53B | $1.70B | $1.30B |
貸借対照表 27
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $420M | $549M | $686M | $315M | $872M | $1.16B | $1.19B | $135M | $137M | $359M | $133M | $192M | |
| Receivables | $1.41B | $1.30B | $1.21B | $1.20B | $1.44B | $1.52B | $1.06B | $1.01B | $924M | $926M | $901M | $932M | |
| Inventory | $189M | $188M | $190M | $192M | $208M | $223M | $123M | $99M | $95M | $82M | $84M | $110M | |
| Prepaid Expense | $361M | $351M | $286M | $196M | $223M | $157M | $112M | $144M | $150M | $155M | $207M | $186M | |
| Current Assets | $2.38B | $2.39B | $2.37B | $1.90B | $2.74B | $3.06B | $2.49B | $1.39B | $1.31B | $1.53B | $1.50B | $1.60B | |
| PP&E (Net) | $2.20B | $2.11B | $1.82B | $1.77B | $1.71B | $1.63B | $1.45B | $1.29B | $1.15B | $1.03B | $925M | $933M | |
| PP&E (Gross) | $6.18B | $5.77B | $5.23B | $5.10B | $4.79B | $4.62B | $4.23B | $3.97B | $3.67B | $3.43B | $3.23B | $3.13B | |
| Accum. Depreciation | $3.97B | $3.66B | $3.42B | $3.34B | $3.09B | $2.99B | $2.78B | $2.68B | $2.53B | $2.40B | $2.31B | $2.19B | |
| Goodwill | $8.95B | $8.86B | $7.73B | $7.22B | $7.09B | $6.87B | $6.62B | $6.56B | $6.33B | $6.00B | $5.91B | $6.03B | |
| Intangibles | $1.64B | $1.76B | $1.17B | $1.09B | $1.17B | $1.17B | $1.12B | $1.21B | $1.12B | $949M | $984M | $1.07B | |
| Other Non-current Assets | $270M | $255M | $198M | $144M | $163M | $176M | $160M | $119M | $136M | $148M | $174M | $172M | |
| Total Assets | $16.23B | $16.15B | $14.02B | $12.84B | $13.61B | $14.03B | $12.84B | $11.00B | $10.50B | $10.10B | $9.96B | $9.86B | |
| Accounts Payable | $1.60B | $1.39B | $1.36B | $1.40B | $1.60B | $1.63B | $1.04B | $1.02B | $1.02B | $975M | $1.01B | $1.19B | |
| Accrued Liabilities | $338M | $306M | $287M | $392M | $460M | $356M | $223M | $274M | $246M | $254M | $257M | $277M | |
| Current Liabilities | $2.28B | $2.17B | $1.81B | $1.55B | $1.75B | $1.78B | $1.99B | $1.49B | $1.06B | $981M | $1.17B | $1.71B | |
| Capital Leases | $537M | $535M | $503M | $489M | $494M | $499M | $413M | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | $264M | $243M | $170M | $191M | $157M | $204M | |
| Other Non-current Liabilities | $957M | $938M | $876M | $812M | $792M | $847M | $711M | $745M | $663M | $654M | $514M | $594M | |
| Long-term Debt | $5.67B | $6.22B | $4.71B | $3.98B | $4.01B | $4.01B | $4.77B | $3.89B | $3.78B | $3.73B | $3.65B | $3.74B | |
| Total Debt | $5.67B | $6.22B | $4.71B | $3.98B | $4.01B | $4.01B | $4.77B | $3.89B | $3.78B | $3.73B | $3.65B | $3.76B | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Retained Earnings | $9.99B | $9.36B | $8.82B | $8.29B | $7.65B | $9.30B | $8.17B | $7.60B | $7.14B | $6.61B | $6.20B | $5.72B | |
| Treasury Stock | $5.18B | $4.86B | $4.83B | $4.67B | $3.45B | $5.37B | $5.22B | $5.00B | $4.78B | $4.46B | $3.96B | $3.81B | |
| AOCI | $-27M | $-88M | $-14M | $-21M | $-14M | $-21M | $-39M | $-59M | $-48M | $-72M | $-38M | $-27M | |
| Stockholders' Equity | $7.17B | $6.78B | $6.31B | $5.89B | $6.44B | $6.76B | $5.64B | $5.22B | $4.92B | $4.63B | $4.68B | $4.30B | |
| Liabilities + Equity | $16.23B | $16.15B | $14.02B | $12.84B | $13.61B | $14.03B | $12.84B | $11.00B | $10.50B | $10.10B | $9.96B | $9.86B | |
| Shares Outstanding | 110,000,000 | 111,000,000 | 111,000,000 | 111,000,000 | 119,000,000 | 133,000,000 | 133,000,000 | 135,000,000 | 135,000,000 | 137,000,000 | 143,000,000 | 144,000,000 |
キャッシュフロー 17
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $570M | $493M | $439M | $437M | $408M | $361M | $329M | $309M | $270M | $249M | $304M | $314M | |
| Stock-based Comp | $88M | $88M | $77M | $77M | $79M | $97M | $56M | $61M | $79M | $69M | $52M | $51M | |
| Deferred Tax | $105M | $13M | $-49M | $1M | $-57M | $85M | $15M | $73M | $9M | $37M | $112M | $23M | |
| Amort. of Intangibles | $154M | $127M | $108M | $120M | $103M | $103M | $96M | $90M | $74M | $72M | $81M | $94M | |
| Restructuring | · | · | · | $55M | $13M | $14M | $-3M | $49M | $30M | $11M | $39M | $43M | |
| Other Non-cash | $131M | $-131M | $-49M | $257M | $-192M | $31M | $-15M | $21M | $45M | $69M | $-367M | $-6M | |
| Operating Cash Flow | $1.89B | $1.33B | $1.27B | $1.72B | $2.23B | $2.00B | $1.24B | $1.20B | $1.18B | $1.12B | $821M | $944M | |
| CapEx | $527M | $425M | $408M | $404M | $403M | $418M | $400M | $383M | $252M | $293M | $263M | $308M | |
| Investing Cash Flow | $-631M | $-2.55B | $-1.06B | $-543M | $21M | $-772M | $-411M | $-801M | $-830M | $-127M | $-362M | $-1.02B | |
| Stock Repurchased | $450M | $151M | $275M | $1.41B | $2.20B | $325M | $353M | $322M | $465M | $590M | $224M | $132M | |
| Net Stock Activity | $-450M | $-151M | $-275M | $-1.41B | $-2.20B | $-325M | $-353M | $-322M | $-465M | $-590M | $-224M | $-132M | |
| Dividends Paid | $353M | $331M | $314M | $305M | $309M | $297M | $286M | $266M | $247M | $223M | $212M | $187M | |
| Financing Cash Flow | $-1.39B | $1.08B | $160M | $-1.73B | $-2.54B | $-1.27B | $225M | $-401M | $-592M | $-738M | $-518M | $86M | |
| Net Change in Cash | $-129M | $-137M | $371M | $-557M | $-286M | · | · | · | $-222M | $226M | $-59M | $5M | |
| Taxes Paid | $169M | $256M | $317M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.36B | $909M | $864M | $1.31B | $1.83B | $1.59B | $843M | $817M | $923M | $776M | $547M | $630M | |
| Levered FCF | · | · | $737M | $1.20B | $1.71B | $1.46B | $704M | $681M | $806M | $689M | · | · |
収益性 8
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 38.5% | 34.8% | 34.6% | 38.8% | 38.6% | 37.9% | 37.6% | |
| Operating Margin | 14.1% | 13.6% | 13.6% | 14.4% | 22.1% | 20.9% | 15.9% | 14.6% | 15.1% | 17.0% | 18.7% | 13.2% | |
| Net Margin | 9.0% | 8.8% | 9.2% | 9.6% | 18.5% | 15.2% | 11.1% | 9.8% | 10.0% | 8.6% | 9.5% | 7.5% | |
| Pretax Margin | 11.9% | 11.9% | 12.2% | 12.5% | 24.1% | 20.0% | 13.9% | 12.3% | 13.4% | 14.4% | 14.7% | · | |
| EBITDA Margin | 19.3% | 18.6% | 18.4% | 18.9% | 25.9% | 24.7% | 20.2% | 18.7% | 18.6% | 20.3% | 22.7% | 17.4% | |
| ROA | 6.1% | 5.8% | 6.4% | 7.1% | 14.4% | 10.7% | 7.2% | 6.8% | 7.5% | 6.4% | 7.1% | 5.9% | |
| ROE | 14.2% | 13.3% | 14.0% | 15.3% | 30.2% | 23.1% | 15.8% | 14.5% | 16.2% | 13.9% | 15.8% | 13.5% | |
| ROIC | 9.2% | 8.0% | 8.9% | 11.4% | 17.5% | 13.8% | 9.1% | 9.7% | 10.2% | 9.2% | 11.1% | · |
流動性と支払能力 5
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 1.1 | 1.3 | 1.2 | 1.6 | 1.7 | 1.3 | 0.9 | 1.2 | 1.6 | 1.3 | 0.9 | |
| Quick Ratio | 0.8 | 0.9 | 1.0 | 1.0 | 1.3 | 1.5 | 1.1 | 0.8 | 1.0 | 1.3 | 0.9 | 0.7 | |
| Debt / Equity | 0.8 | 0.9 | 0.7 | 0.7 | 0.6 | 0.6 | 0.8 | 0.7 | 0.8 | 0.8 | 0.8 | 0.9 | |
| LT Debt / Equity | 0.7 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.7 | 0.8 | 0.8 | 0.7 | 0.8 | |
| Interest Coverage | · | · | 7.7 | 9.6 | 15.7 | 11.9 | 6.8 | 6.5 | 7.6 | 8.9 | · | · |
効率性 3
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | 0.7 | 0.6 | 0.7 | 0.7 | 0.7 | 0.8 | 0.8 | |
| Inventory Turnover | 39.1 | 35.1 | 32.5 | 32.2 | 30.5 | 33.5 | 45.4 | 50.8 | 53.3 | 55.6 | 48.0 | 46.1 | |
| Receivables Turnover | 8.1 | 7.9 | 7.7 | 7.5 | 7.3 | 7.3 | 7.4 | 7.8 | 8.3 | 8.2 | 8.2 | 8.3 |
成長率 10
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.8% | 6.7% | -6.4% | -8.4% | 14.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 3.7% | -2.9% | -0.66% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.2% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 13.8% | 2.7% | -6.0% | -48.8% | 48.5% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 3.2% | -20.9% | -10.6% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -3.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 13.9% | 2.0% | -9.7% | -52.6% | 39.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 1.6% | -24.1% | -15.8% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -7.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 3.5% | · | · | · | · | · | · | · | · | · | · | · |
バリュエーション（TTM） 16
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $11.04B | $9.87B | $9.25B | $9.88B | $10.79B | $9.44B | $7.73B | $7.53B | $7.40B | $7.21B | $7.49B | $7.43B | |
| Net Income TTM | $992M | $871M | $854M | $946M | $2.00B | $1.43B | $858M | $736M | $772M | $645M | $709M | $556M | |
| Market Cap | $19.09B | $16.75B | $15.30B | $17.36B | $20.59B | $15.85B | $14.20B | $11.24B | $13.30B | $12.59B | $10.17B | $9.66B | |
| Enterprise Value | $24.34B | $22.41B | $19.33B | $21.03B | $23.73B | $18.71B | $17.78B | $15.00B | $16.94B | $15.97B | $13.69B | $13.23B | |
| P/E | 19.8 | 19.6 | 18.4 | 19.6 | 11.1 | 11.4 | 17.0 | 15.7 | 17.9 | 20.4 | 14.6 | 17.6 | |
| P/S | 1.7 | 1.7 | 1.7 | 1.8 | 1.9 | 1.7 | 1.8 | 1.5 | 1.8 | 1.7 | 1.4 | 1.3 | |
| P/B | 2.7 | 2.5 | 2.4 | 2.9 | 3.2 | 2.3 | 2.5 | 2.2 | 2.7 | 2.7 | 2.2 | 2.2 | |
| P / Cash Flow | 10.1 | 12.6 | 12.0 | 10.1 | 9.2 | 7.9 | 11.4 | 9.4 | 11.3 | 11.8 | 12.6 | 10.3 | |
| P / FCF | 14.0 | 18.4 | 17.7 | 13.2 | 11.3 | 10.0 | 16.8 | 13.8 | 14.4 | 16.2 | 18.6 | 15.3 | |
| EV / EBITDA | 11.4 | 12.2 | 11.4 | 11.3 | 8.5 | 8.0 | 11.4 | 10.6 | 11.8 | 10.5 | 8.0 | 10.2 | |
| EV / FCF | 17.9 | 24.7 | 22.4 | 16.0 | 13.0 | 11.8 | 21.1 | 18.4 | 18.4 | 20.6 | 25.0 | 21.0 | |
| EV / Revenue | 2.2 | 2.3 | 2.1 | 2.1 | 2.2 | 2.0 | 2.3 | 2.0 | 2.3 | 2.2 | 1.8 | 1.8 | |
| Dividend Yield | 1.8% | 2.0% | 2.1% | 1.8% | 1.5% | 1.9% | 2.0% | 2.4% | 1.9% | 1.8% | 2.1% | 1.9% | |
| Earnings Yield | 5.0% | 5.1% | 5.4% | 5.1% | 9.0% | 8.8% | 5.9% | 6.3% | 5.6% | 4.9% | 6.9% | 5.7% | |
| Payout Ratio | 35.6% | 38.0% | 36.8% | 32.2% | 15.5% | 20.8% | 33.3% | 36.1% | 32.0% | 34.6% | 29.9% | 33.6% | |
| Annual Payout | $353M | $331M | $314M | $305M | $309M | $297M | $286M | $266M | $247M | $223M | $212M | $187M |
損益計算書 16
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.04B | $2.90B | $2.81B | $2.82B | $2.76B | $2.65B | $2.62B | $2.49B | $2.40B | $2.37B | $2.29B | $2.29B | $2.34B | $2.33B | $2.33B | $2.49B | |
| Cost of Revenue | $2.02B | $1.95B | $1.90B | $1.87B | $1.82B | $1.79B | $1.76B | $1.68B | $1.59B | $1.59B | $1.55B | $1.54B | $1.55B | $1.56B | $1.57B | $1.62B | |
| SG&A Expense | $529M | $504M | $504M | $501M | $486M | $476M | $466M | $448M | $416M | $440M | $407M | $380M | $416M | $439M | $563M | $464M | |
| Operating Expenses | $2.58B | $2.50B | $2.42B | $2.43B | $2.32B | $2.31B | $2.26B | $2.16B | $2.04B | $2.07B | $2.02B | $1.95B | $1.99B | $2.03B | $2.20B | $2.09B | |
| Operating Income | $459M | $399M | $386M | $386M | $438M | $346M | $361M | $330M | $355M | $300M | $267M | $342M | $348M | $305M | $135M | $392M | |
| Interest Expense | · | · | · | · | · | · | · | · | $47M | $49M | · | $41M | $39M | $37M | · | $37M | |
| Interest Income | $5M | $2M | $3M | $3M | $2M | $5M | $7M | $9M | $3M | $6M | $6M | $1M | $2M | $2M | $4M | $4M | |
| Other Non-op | $16M | $-2M | $8M | $8M | $13M | $-3M | $3M | $15M | $3M | $9M | $10M | $-3M | $6M | $7M | $6M | $-8M | |
| Pretax Income | $412M | $334M | $330M | $328M | $384M | $276M | $299M | $296M | $314M | $266M | $237M | $299M | $317M | $277M | $109M | $351M | |
| Income Tax | $88M | $74M | $81M | $77M | $97M | $59M | $68M | $65M | $74M | $66M | $40M | $68M | $75M | $65M | $-4M | $81M | |
| Net Income | $320M | $252M | $245M | $245M | $282M | $220M | $222M | $226M | $229M | $194M | $192M | $225M | $235M | $202M | $101M | $256M | |
| EPS (Basic) | $2.88 | $2.27 | $2.21 | $2.18 | $2.51 | $1.97 | $1.98 | $2.01 | $2.05 | $1.74 | $1.72 | $1.99 | $2.08 | $1.80 | $0.93 | $2.20 | |
| EPS (Diluted) | $2.84 | $2.24 | $2.18 | $2.16 | $2.47 | $1.94 | $1.95 | $1.99 | $2.03 | $1.72 | $1.70 | $1.96 | $2.05 | $1.78 | $0.92 | $2.17 | |
| Shares (Basic) | 111,000,000 | 110,000,000 | -224,000,000 | 112,000,000 | 112,000,000 | 111,000,000 | -223,000,000 | 112,000,000 | 111,000,000 | 111,000,000 | -224,000,000 | 112,000,000 | 112,000,000 | 112,000,000 | -236,000,000 | 116,000,000 | |
| Shares (Diluted) | 112,000,000 | 112,000,000 | -226,000,000 | 113,000,000 | 113,000,000 | 113,000,000 | -224,000,000 | 113,000,000 | 112,000,000 | 112,000,000 | -228,000,000 | 114,000,000 | 114,000,000 | 113,000,000 | -240,000,000 | 118,000,000 | |
| EBITDA | $605M | $546M | · | $528M | $581M | $486M | · | $455M | $472M | $416M | · | $453M | $460M | $412M | · | $500M |
貸借対照表 26
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $626M | $393M | $420M | $432M | $319M | $188M | $549M | $764M | $271M | $474M | · | $143M | $126M | $175M | · | $700M | |
| Receivables | $1.67B | $1.59B | $1.41B | $1.46B | $1.42B | $1.40B | $1.30B | $1.38B | $1.32B | $1.32B | · | $1.28B | $1.24B | $1.25B | · | $1.28B | |
| Inventory | $233M | $225M | $189M | $186M | $187M | $189M | $188M | $184M | $182M | $181M | · | $184M | $184M | $190M | · | $183M | |
| Prepaid Expense | $319M | $361M | $361M | $333M | $273M | $294M | $351M | $299M | $245M | $251M | · | $207M | $188M | $195M | · | $171M | |
| Current Assets | $2.84B | $2.57B | $2.38B | $2.41B | $2.20B | $2.08B | $2.39B | $2.62B | $2.02B | $2.23B | · | $1.81B | $1.73B | $1.81B | · | $2.33B | |
| PP&E (Net) | $2.22B | $2.19B | $2.20B | $2.15B | $2.12B | $2.10B | $2.11B | $2.09B | $1.83B | $1.81B | · | $1.83B | $1.81B | $1.79B | · | $1.71B | |
| PP&E (Gross) | · | · | $6.18B | · | · | · | $5.77B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $3.97B | · | · | · | $3.66B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $9.11B | $9.12B | $8.95B | $8.90B | $8.88B | $8.85B | $8.86B | $8.61B | $7.88B | $7.83B | $7.73B | $7.73B | $7.73B | $7.24B | $7.22B | $7.19B | |
| Intangibles | $1.67B | $1.72B | $1.64B | $1.66B | $1.71B | $1.73B | $1.76B | $1.72B | $1.20B | $1.19B | · | $1.22B | $1.25B | $1.08B | · | $1.11B | |
| Other Non-current Assets | $277M | $256M | $270M | $296M | $271M | $260M | $255M | $272M | $216M | $182M | · | $149M | $152M | $150M | · | $132M | |
| Total Assets | $16.94B | $16.67B | $16.23B | $16.20B | $15.97B | $15.80B | $16.15B | $16.09B | $13.88B | $13.95B | · | $13.48B | $13.43B | $12.79B | · | $13.22B | |
| Accounts Payable | $1.60B | $1.50B | $1.60B | $1.46B | $1.35B | $1.27B | $1.39B | $1.31B | $1.25B | $1.24B | · | $1.16B | $1.20B | $1.20B | · | $1.45B | |
| Accrued Liabilities | · | · | $338M | · | · | · | $306M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $1.79B | $2.18B | $2.28B | $2.13B | $2.02B | $1.44B | $2.17B | $2.09B | $2.01B | $2.30B | · | $1.62B | $1.88B | $1.35B | · | $1.60B | |
| Capital Leases | $561M | $574M | $537M | $534M | $540M | $538M | $535M | $543M | $507M | $489M | · | $505M | $508M | $490M | · | $505M | |
| Other Non-current Liabilities | $1.06B | $1.02B | $957M | $982M | $890M | $917M | $938M | $891M | $811M | $817M | · | $874M | $901M | $809M | · | $787M | |
| Long-term Debt | $5.64B | · | $5.67B | · | · | · | $6.22B | $6.25B | · | · | · | · | · | · | · | · | |
| Total Debt | $5.64B | $503M | · | $504M | $504M | $1M | · | $6.25B | $606M | $906M | · | $304M | $518M | $2M | · | $2M | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Retained Earnings | $10.37B | $10.15B | $9.99B | $9.84B | $9.68B | $9.49B | $9.36B | $9.22B | $9.08B | $8.94B | · | $8.71B | $8.57B | $8.41B | · | $8.26B | |
| Treasury Stock | $5.17B | $5.09B | $5.18B | $4.90B | $4.77B | $4.79B | $4.86B | $4.73B | $4.76B | $4.78B | · | $4.57B | $4.59B | $4.61B | · | $4.27B | |
| AOCI | $-62M | $-43M | $-27M | $-40M | $-16M | $-83M | $-88M | $-15M | $-19M | $-16M | · | $-20M | $-16M | $-18M | · | $-31M | |
| Stockholders' Equity | $7.52B | $7.37B | $7.17B | $7.26B | $7.23B | $6.93B | $6.78B | $6.81B | $6.62B | $6.43B | · | $6.42B | $6.25B | $6.05B | · | $6.24B | |
| Liabilities + Equity | $16.94B | $16.67B | $16.23B | $16.20B | $15.97B | $15.80B | $16.15B | $16.09B | $13.88B | $13.95B | · | $13.48B | $13.43B | $12.79B | · | $13.22B | |
| Shares Outstanding | 110,000,000 | 111,000,000 | 110,000,000 | 111,000,000 | 112,000,000 | 112,000,000 | 111,000,000 | 112,000,000 | 111,000,000 | 111,000,000 | 111,000,000 | 112,000,000 | 112,000,000 | 112,000,000 | 111,000,000 | 114,000,000 |
キャッシュフロー 16
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $146M | $147M | $145M | $142M | $143M | $140M | $135M | $125M | $117M | $116M | $109M | $111M | $112M | $107M | $116M | $108M | |
| Stock-based Comp | $23M | $20M | $25M | $20M | $21M | $22M | $27M | $19M | $20M | $22M | $19M | $18M | $16M | $24M | $22M | $18M | |
| Deferred Tax | $-2M | $48M | $-13M | $110M | $1M | $7M | $34M | $15M | $-18M | $-18M | $-10M | $-23M | $-12M | $-4M | $-44M | $65M | |
| Amort. of Intangibles | $38M | $37M | $37M | $39M | $39M | $39M | $37M | $32M | $29M | $29M | $27M | $27M | $28M | $26M | $39M | $27M | |
| Restructuring | · | · | · | $6M | $1M | · | · | $7M | $8M | · | · | $1M | $1M | · | · | · | |
| Other Non-cash | · | $-189M | · | · | · | $-75M | · | · | · | $-160M | · | · | · | $-235M | · | · | |
| Operating Cash Flow | $597M | $278M | $465M | $563M | $544M | $314M | $464M | $356M | $360M | $154M | $527M | $207M | $444M | $94M | $334M | $502M | |
| CapEx | $138M | $114M | $158M | $144M | $108M | $117M | $123M | $106M | $92M | $104M | $72M | $105M | $104M | $127M | $147M | $118M | |
| Investing Cash Flow | $-134M | $-152M | $-191M | $-201M | $-124M | $-115M | $-502M | $-1.63B | $-200M | $-213M | $-114M | $-107M | $-682M | $-158M | $-174M | $-118M | |
| Stock Repurchased | · | · | $300M | $150M | · | · | $151M | · | · | · | $275M | $0 | $0 | $0 | $461M | $374M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Dividends Paid | $96M | $88M | $90M | $89M | $90M | $84M | $84M | $84M | $84M | $79M | $80M | $80M | $80M | $74M | $75M | $78M | |
| Financing Cash Flow | $-229M | $-152M | $-287M | $-247M | $-293M | $-561M | $-170M | $1.77B | $-363M | $-153M | $130M | $-83M | $189M | $-76M | $-545M | $-474M | |
| Net Change in Cash | $233M | $-27M | $-12M | $113M | $131M | $-361M | $-215M | $493M | $-203M | $-212M | $543M | $17M | $-49M | $-140M | $-385M | $-90M | |
| Free Cash Flow | · | $164M | · | · | · | $197M | · | · | · | $50M | · | · | · | $-33M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $13M | · | · | · | $-61M | · | · |
収益性 7
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.1% | 13.8% | · | 13.7% | 15.9% | 13.1% | · | 13.3% | 14.8% | 12.7% | · | 14.9% | 14.9% | 13.1% | · | 15.8% | |
| Net Margin | 10.5% | 8.7% | · | 8.7% | 10.2% | 8.3% | · | 9.1% | 9.6% | 8.2% | · | 9.8% | 10.1% | 8.7% | · | 10.3% | |
| Pretax Margin | 13.5% | 11.5% | · | 11.7% | 13.9% | 10.4% | · | 11.9% | 13.1% | 11.2% | · | 13.0% | 13.6% | 11.9% | · | 14.1% | |
| EBITDA Margin | 19.9% | 18.9% | · | 18.8% | 21.0% | 18.3% | · | 18.3% | 19.7% | 17.6% | · | 19.7% | 19.7% | 17.7% | · | 20.1% | |
| ROA | 1.9% | 1.6% | · | 1.5% | 1.9% | 1.5% | · | 1.5% | 1.7% | 1.5% | · | 1.7% | 1.8% | 1.5% | · | 1.9% | |
| ROE | 4.3% | 3.5% | · | 3.5% | 4.1% | 3.3% | · | 3.4% | 3.6% | 3.1% | · | 3.5% | 3.7% | 3.2% | · | 4.0% | |
| ROIC | 2.7% | 4.0% | · | 3.8% | 4.2% | 3.9% | · | 2.0% | 3.8% | 3.1% | · | 3.9% | 3.9% | 3.9% | · | 4.8% |
流動性と支払能力 5
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.2 | · | 1.1 | 1.1 | 1.4 | · | 1.3 | 1.0 | 1.0 | · | 1.1 | 0.9 | 1.3 | · | 1.5 | |
| Quick Ratio | 1.3 | 0.9 | · | 0.9 | 0.9 | 1.1 | · | 1.0 | 0.8 | 0.8 | · | 0.9 | 0.7 | 1.1 | · | 1.2 | |
| Debt / Equity | 0.8 | 0.1 | · | 0.1 | 0.1 | 0.0 | · | 0.9 | 0.1 | 0.1 | · | 0.0 | 0.1 | 0.0 | · | 0.0 | |
| LT Debt / Equity | 0.7 | · | · | · | · | · | · | 0.8 | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | 7.6 | 6.1 | · | 8.3 | 8.9 | 8.2 | · | 10.6 |
効率性 3
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 9.6 | 9.4 | · | 10.1 | 9.9 | 9.7 | · | 9.1 | 8.7 | 8.6 | · | 8.4 | 8.3 | 8.1 | · | 8.3 | |
| Receivables Turnover | 2.0 | 1.9 | · | 2.0 | 2.0 | 1.9 | · | 1.9 | 1.9 | 1.8 | · | 1.8 | 1.8 | 1.8 | · | 1.8 |
バリュエーション（TTM） 14
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $11.52B | $11.12B | · | $10.72B | $10.30B | $9.90B | · | $9.55B | $9.40B | $9.33B | · | $9.45B | $9.61B | $9.88B | · | $10.32B | |
| Net Income TTM | $1.10B | $999M | · | $973M | $957M | $869M | · | $874M | $883M | $856M | · | $918M | $927M | $1.05B | · | $1.35B | |
| Market Cap | $23.31B | $21.75B | · | $21.15B | $20.12B | $18.95B | · | $17.39B | $15.19B | $14.78B | · | $13.65B | $15.74B | $15.85B | · | $13.99B | |
| Enterprise Value | $28.33B | $21.86B | · | $21.23B | $20.30B | $18.76B | · | $22.88B | $15.53B | $15.21B | · | $13.81B | $16.13B | $15.67B | · | $13.29B | |
| P/E | 21.8 | 22.2 | · | 22.3 | 21.3 | 22.0 | · | 20.2 | 17.6 | 17.7 | · | 15.3 | 17.7 | 16.0 | · | 11.1 | |
| P/S | 2.0 | 2.0 | · | 2.0 | 2.0 | 1.9 | · | 1.8 | 1.6 | 1.6 | · | 1.4 | 1.6 | 1.6 | · | 1.4 | |
| P/B | 3.1 | 3.0 | · | 2.9 | 2.8 | 2.7 | · | 2.6 | 2.3 | 2.3 | · | 2.1 | 2.5 | 2.6 | · | 2.2 | |
| P / Cash Flow | · | 78.3 | · | · | · | 60.4 | · | · | · | 95.9 | · | · | · | 168.6 | · | · | |
| P / FCF | · | 132.6 | · | · | · | 96.2 | · | · | · | 295.5 | · | · | · | -480.2 | · | · | |
| EV / EBITDA | 46.8 | 40.0 | · | 40.2 | 34.9 | 38.6 | · | 50.3 | 32.9 | 36.6 | · | 30.5 | 35.1 | 38.0 | · | 26.6 | |
| EV / FCF | · | 133.3 | · | · | · | 95.2 | · | · | · | 304.1 | · | · | · | -474.9 | · | · | |
| EV / Revenue | 2.5 | 2.0 | · | 2.0 | 2.0 | 1.9 | · | 2.4 | 1.7 | 1.6 | · | 1.5 | 1.7 | 1.6 | · | 1.3 | |
| Earnings Yield | 4.6% | 4.5% | · | 4.5% | 4.7% | 4.5% | · | 5.0% | 5.7% | 5.6% | · | 6.5% | 5.7% | 6.2% | · | 9.0% | |
| Payout Ratio | · | 34.9% | · | · | · | 38.2% | · | · | · | 40.7% | · | · | · | 36.6% | · | · |
財務諸表 損益計算書、貸借対照表、キャッシュフロー — 年次、過去5年間
損益計算書
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 収益 | $11.04B | $9.87B | $9.25B | $9.88B | $10.79B |
| 営業利益率 % | 14.1% | 13.6% | 13.6% | 14.4% | 22.1% |
| 純利益 | $992M | $871M | $854M | $946M | $2.00B |
| 希薄化後EPS | $8.75 | $7.69 | $7.49 | $7.97 | $15.55 |
貸借対照表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 負債資本倍率 | 0.8 | 0.9 | 0.7 | 0.7 | 0.6 |
| 流動比率 | 1.0 | 1.1 | 1.3 | 1.2 | 1.6 |
| クイックレシオ | 0.8 | 0.9 | 1.0 | 1.0 | 1.3 |
キャッシュフロー
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| フリーキャッシュフロー | $1.36B | $909M | $864M | $1.31B | $1.83B |
最新ニュース この会社に言及した最近の見出し
マイ指標 あなた専用のウォッチリスト — 決算詳細から選択した行
📊
あなたにとって重要なメトリクスを選択 — 上記の決算詳細の任意の行の横にある➕をクリックしてください。
選択内容は保存され、すべてのティッカーで引き継がれます。
機関投資家（13F） 1,175 提出者 · $12.9B合計 · 時点 2026年6月30日
四半期SECフォーム13Fでこの株式の保有を報告している機関。ロングポジションのみ。単一の提出者は、別々のオプションレッグで2回表示される場合があります。 大きな反対売買のプット/コール・レッグは、通常、マーケットメイクまたはヘッジされた在庫を反映しており、方向性への確信を示すものではありません。
機関投資家の動向 — Q2 2026 対 前四半期
| 新規ポジション | 解消済みポジション | 増加 | 減少 | 純株式数増減 |
|---|---|---|---|---|
| 121 (-13 前期比) | 63 (-19 前期比) | 408 (+62 前期比) | 330 (-21 前期比) | +21.9M |
Q1 2026と比較しました。 SECフォーム13Fの提出期限は四半期末から45日後ですが、遅延提出者向けの短いバッファーが含まれます。この期間内の四半期は、直近で完全に報告されたペアを優先するためスキップされます。
| 機関投資家 | 評価額 | 株式数 | % 追跡された13Fのうち | タイプ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1,533,117,858 | 7,233,394 | 11.92% | 株式数 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,299,474,988 | 6,131,045 | 10.11% | 株式数 |
| STATE STREET CORP | $1,169,252,484 | 5,516,643 | 9.09% | 株式数 |
| GEODE CAPITAL MANAGEMENT, LLC | $584,135,885 | 2,767,754 | 4.54% | 株式数 |
| EdgePoint Investment Group Inc. | $476,372,038 | 2,247,568 | 3.71% | 株式数 |
| Grantham, Mayo, Van Otterloo & Co. LLC | $400,206,122 | 1,888,207 | 3.11% | 株式数 |
| DIMENSIONAL FUND ADVISORS LP | $357,050,202 | 1,684,597 | 2.78% | 株式数 |
| Davis Selected Advisers | $329,781,509 | 1,555,612 | 2.57% | 株式数 |
| VICTORY CAPITAL MANAGEMENT INC | $311,037,928 | 1,467,506 | 2.42% | 株式数 |
| NORGES BANK | $298,133,109 | 1,406,620 | 2.32% | 株式数 |
| FMR LLC | $227,315,614 | 1,072,496 | 1.77% | 株式数 |
| AMERICAN CENTURY COMPANIES INC | $173,422,135 | 818,220 | 1.35% | 株式数 |
| M&G PLC | $168,677,800 | 795,650 | 1.31% | 株式数 |
| VANGUARD FIDUCIARY TRUST CO | $131,756,386 | 621,639 | 1.02% | 株式数 |
| ALLIANCEBERNSTEIN L.P. | $122,662,706 | 625,894 | 0.95% | 株式数 |
| AMERIPRISE FINANCIAL INC | $109,652,758 | 517,352 | 0.85% | 株式数 |
| Woodline Partners LP | $102,974,000 | 485,841 | 0.80% | 株式数 |
| FIDUCIARY MANAGEMENT INC /WI/ | $102,489,906 | 483,557 | 0.80% | 株式数 |
| Artemis Investment Management LLP | $99,175,856 | 467,921 | 0.77% | 株式数 |
| CRAWFORD INVESTMENT COUNSEL INC | $97,514,204 | 460,081 | 0.76% | 株式数 |
| PRINCIPAL FINANCIAL GROUP INC | $91,995,201 | 434,042 | 0.72% | 株式数 |
| ENVESTNET ASSET MANAGEMENT INC | $90,834,224 | 428,564 | 0.71% | 株式数 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $86,608,697 | 407,302 | 0.67% | 株式数 |
| BNP PARIBAS FINANCIAL MARKETS | $83,772,178 | 395,245 | 0.65% | 株式数 |
| M.D. Sass, LLC | $76,397,960 | 360,453 | 0.59% | 株式数 |
| Qube Research & Technologies Ltd | $72,783,206 | 343,398 | 0.57% | 株式数 |
| MACKENZIE FINANCIAL CORP | $70,641,875 | 333,295 | 0.55% | 株式数 |
| Advisors Capital Management, LLC | $69,429,626 | 327,575 | 0.54% | 株式数 |
| Swiss National Bank | $65,683,305 | 309,900 | 0.51% | 株式数 |
| Balyasny Asset Management L.P. | $58,364,883 | 275,371 | 0.45% | 株式数 |
| Mitsubishi UFJ Asset Management Co., Ltd. | $56,877,630 | 268,354 | 0.44% | 株式数 |
| RHUMBLINE ADVISERS | $56,744,612 | 267,727 | 0.44% | 株式数 |
| BlackRock, Inc. | $55,976,419 | 264,102 | 0.44% | 株式数 |
| Sumitomo Mitsui Trust Group, Inc. | $54,809,634 | 258,597 | 0.43% | 株式数 |
| VANGUARD ASSET MANAGEMENT, Ltd | $53,654,295 | 253,146 | 0.42% | 株式数 |
| Quantinno Capital Management LP | $53,607,358 | 252,924 | 0.42% | 株式数 |
| RAYMOND JAMES FINANCIAL INC | $53,249,860 | 251,238 | 0.41% | 株式数 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $52,211,551 | 246,339 | 0.41% | 株式数 |
| VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | $51,484,139 | 242,907 | 0.40% | 株式数 |
| Clark Capital Management Group, Inc. | $51,259,362 | 241,846 | 0.40% | 株式数 |
| Vanguard Global Advisers, LLC | $51,025,267 | 240,742 | 0.40% | 株式数 |
| Legal & General Group Plc | $50,185,731 | 236,781 | 0.39% | 株式数 |
| FIL Ltd | $49,419,958 | 233,168 | 0.38% | 株式数 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $49,341,000 | 232,797 | 0.38% | 株式数 |
| Eurizon Capital SGR S.p.A. | $47,173,414 | 222,564 | 0.37% | 株式数 |
| BARCLAYS PLC | $45,003,978 | 212,333 | 0.35% | 株式数 |
| PFA Pension, Forsikringsaktieselskab | $43,579,660 | 205,613 | 0.34% | 株式数 |
| Integral Health Asset Management, LLC | $42,390,000 | 200,000 | 0.33% | 株式数 |
| California Public Employees Retirement System | $41,574,204 | 196,151 | 0.32% | 株式数 |
| CONNING INC. | $39,578,271 | 186,734 | 0.31% | 株式数 |
| SEB Asset Management AB | $38,766,863 | 182,906 | 0.30% | 株式数 |
| BANK OF MONTREAL /CAN/ | $38,512,587 | 181,706 | 0.30% | 株式数 |
| GOLDMAN SACHS GROUP INC | $38,322,295 | 180,808 | 0.30% | 株式数 |
| Boston Partners | $35,509,632 | 167,514 | 0.28% | 株式数 |
| Focus Partners Wealth | $34,616,947 | 163,327 | 0.27% | 株式数 |
| STOREBRAND ASSET MANAGEMENT AS | $34,117,592 | 160,970 | 0.27% | 株式数 |
| COOKSON PEIRCE & CO INC | $32,977,089 | 155,589 | 0.26% | 株式数 |
| UBS Group AG | $32,934,699 | 155,389 | 0.26% | 株式数 |
| BRAUN STACEY ASSOCIATES INC | $32,724,232 | 154,396 | 0.25% | 株式数 |
| Willis Investment Counsel | $32,110,425 | 151,500 | 0.25% | 株式数 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $31,795,403 | 162,238 | 0.25% | 株式数 |
| LPL Financial LLC | $30,325,576 | 143,079 | 0.24% | 株式数 |
| APG Asset Management N.V. | $27,869,580 | 150,334 | 0.22% | 株式数 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $26,893,912 | 126,888 | 0.21% | 株式数 |
| &PARTNERS | $26,382,365 | 124,363 | 0.21% | 株式数 |
| JANE STREET GROUP, LLC | $25,942,680 | 122,400 | 0.20% | コールオプション |
| BANK OF AMERICA CORP /DE/ | $25,492,499 | 120,276 | 0.20% | 株式数 |
| Candriam S.C.A. | $25,459,925 | 120,238 | 0.20% | 株式数 |
| Squarepoint Ops LLC | $24,974,280 | 117,831 | 0.19% | 株式数 |
| Gotham Asset Management, LLC | $24,911,119 | 117,533 | 0.19% | 株式数 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $24,607,896 | 116,373 | 0.19% | 株式数 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $24,569,456 | 115,921 | 0.19% | 株式数 |
| Robeco Institutional Asset Management B.V. | $23,854,123 | 112,546 | 0.19% | 株式数 |
| AEGON ASSET MANAGEMENT UK Plc | $22,866,862 | 107,888 | 0.18% | 株式数 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | $22,670,926 | 106,964 | 0.18% | 株式数 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $22,530,921 | 106,303 | 0.18% | 株式数 |
| MERCER GLOBAL ADVISORS INC /ADV | $22,064,117 | 104,101 | 0.17% | 株式数 |
| Moran Wealth Management, LLC | $22,053,609 | 104,051 | 0.17% | 株式数 |
| ABN AMRO Bank N.V. | $21,523,733 | 101,667 | 0.17% | 株式数 |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $21,496,202 | 123,876 | 0.17% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $21,322,170 | 100,600 | 0.17% | コールオプション |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $21,146,252 | 99,770 | 0.16% | 株式数 |
| AVIVA PLC | $20,378,569 | 96,148 | 0.16% | 株式数 |
| SCHWARTZ INVESTMENT COUNSEL INC | $20,326,005 | 95,900 | 0.16% | 株式数 |
| Boston Common Asset Management, LLC | $20,282,767 | 95,696 | 0.16% | 株式数 |
| CAPTRUST FINANCIAL ADVISORS | $20,146,790 | 95,054 | 0.16% | 株式数 |
| Midwest Trust Co | $20,113,207 | 94,896 | 0.16% | 株式数 |
| LAZARD ASSET MANAGEMENT LLC | $20,035,210 | 94,528 | 0.16% | 株式数 |
| FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | $19,842,759 | 93,620 | 0.15% | 株式数 |
| BLAIR WILLIAM & CO/IL | $19,773,115 | 93,291 | 0.15% | 株式数 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $19,613,005 | 92,536 | 0.15% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $19,160,280 | 90,400 | 0.15% | プットオプション |
| CITADEL ADVISORS LLC | $18,821,160 | 88,800 | 0.15% | コールオプション |
| WELLINGTON MANAGEMENT GROUP LLP | $17,507,282 | 82,601 | 0.14% | 株式数 |
| Foundry Partners, LLC | $17,338,432 | 102,473 | 0.13% | 株式数 |
| MARSHALL WACE, LLP | $17,187,874 | 81,094 | 0.13% | 株式数 |
| Coho Partners, Ltd. | $16,981,317 | 89,103 | 0.13% | 株式数 |
| Copeland Capital Management, LLC | $16,902,800 | 79,749 | 0.13% | 株式数 |
| CIBC Asset Management Inc | $16,674,318 | 78,671 | 0.13% | 株式数 |
| Mitsubishi UFJ Trust & Banking Corp | $16,558,594 | 78,125 | 0.13% | 株式数 |
企業インサイダー 53 人のインサイダー · 26人の役員 · 26人の取締役
| インサイダー | 役職 | 最終アクティビティ | 保有株式数 | 12ヶ月購入 | 12ヶ月売却 | 12ヶ月純額 |
|---|---|---|---|---|---|---|
| E. J. Davis | CEO and President | 2026年6月1日 S | 132,423 | 0 | 5 | $-14,656,302 |
| Surya N Mohapatra | Chairman, President & CEO | 2012年4月30日 F | 243,713 | 0 | 0 | $0 |
| Sam Samad | Executive Vice President & CFO | 2026年7月22日 A | 33,478 | 0 | 0 | $0 |
| Mark Guinan | Executive Vice President & CFO | 2022年3月7日 F | 98,981 | 0 | 0 | $0 |
| Robert Hagemann | SVP & Chief Financial Officer | 2013年3月5日 F | 126,722 | 0 | 0 | $0 |
| Mark E Delaney | SVP & Chief Commercial Officer | 2026年7月28日 S | 10,335 | 0 | 1 | $-376,288 |
| Karthik Kuppusamy | SVP, Clinical Solutions | 2026年7月22日 L | 13,557 | 0 | 2 | $-2,167,772 |
| Patrick Plewman | SVP for Diagnostic Services | 2026年7月22日 L | 15,293 | 0 | 5 | $-3,023,678 |
| Catherine T. Doherty | EVP, Regional Businesses | 2026年3月5日 S | 67,122 | 0 | 7 | $-6,671,228 |
| Michael E Prevoznik | SVP & General Counsel | 2026年3月5日 S | 37,557 | 0 | 7 | $-6,505,199 |
| Michael J Deppe | SVP, Corp. Controller & CAO | 2026年3月4日 F | 35,196 | 0 | 0 | $0 |
| Mark A Gardner | SVP of Molecular Gen & Oncol | 2024年9月24日 F | 4,673 | 0 | 0 | $0 |
| Manner Carrie Eglinton | SVP, Advanced Diagnostics | 2022年3月7日 F | 48,391 | 0 | 0 | $0 |
| Manuel O. Mendez | SVP & Chief Commercial Officer | 2021年2月17日 A | 29,045 | 0 | 0 | $0 |
| Robert A Klug | VP, Corporate Controller | 2019年3月1日 F | 6,261 | 0 | 0 | $0 |
| Jon R Cohen | SVP & Group Exec. Diag. Sol. | 2018年3月8日 M | 31,757 | 0 | 0 | $0 |
| Everett Cunningham | SVP, Commercial | 2018年3月1日 G | 37,760 | 0 | 0 | $0 |
| Thomas F Bongiorno | VP and Corporate Controller | 2015年3月2日 F | 11,837 | 0 | 0 | $0 |
| John B. Haydon | SVP, Operations | 2014年2月13日 A | 19,890 | 0 | 0 | $0 |
| Kathy Ordonez | SVP, Diagnostic Solutions | 2013年3月31日 F | 9,569 | 0 | 0 | $0 |
| Joan Elizabeth Miller | SVP-Oncology & Neurology Srvcs | 2012年2月29日 F | 89,232 | 0 | 0 | $0 |
| Wayne R. Simmons | Vice President, Operations | 2011年6月16日 M | 47,150 | 0 | 0 | $0 |
| Robert E Peters | VP, Sales & Marketing | 2007年2月12日 A | 12,974 | 0 | 0 | $0 |
| David M Zewe | SVP, Diagnostic Testing Ops | 2007年2月12日 A | 31,079 | 0 | 0 | $0 |
| GRANT THOMAS W II | Sr VP, Ins. & Employer Serv. | 2007年2月12日 A | — | 0 | 0 | $0 |
| Gerald C Marrone | SVP, Administration | 2004年2月28日 F | 49,609 | 0 | 0 | $0 |
| Wright Lassiter III | 取締役 | 2026年7月22日 L | 10,323 | 0 | 0 | $0 |
| Vicky B Gregg | 取締役 | 2026年7月22日 A | 18,386 | 0 | 1 | $-239,700 |
| Robert B Carter | 取締役 | 2026年7月22日 L | 3,864 | 0 | 0 | $0 |
| Timothy L Main | 取締役 | 2026年7月22日 L | 22,460 | 0 | 0 | $0 |
| Timothy C Wentworth | 取締役 | 2026年7月1日 A | 1,358 | 0 | 0 | $0 |
| Timothy M Ring | 取締役 | 2026年5月20日 A | 31,140 | 0 | 0 | $0 |
| Gary M Pfeiffer | 取締役 | 2026年5月20日 A | 31,005 | 0 | 1 | $-270,317 |
| Luis Diaz | 取締役 | 2025年5月15日 A | 4,054 | 0 | 0 | $0 |
| Tracey Doi | 取締役 | 2025年5月15日 A | 6,490 | 0 | 0 | $0 |
| Gail R Wilensky | 取締役 | 2023年5月17日 A | 20,506 | 0 | 0 | $0 |
| Stephen H Rusckowski | 取締役 | 2023年3月6日 F | 389,597 | 0 | 0 | $0 |
| Helen Torley | 取締役 | 2021年5月25日 A | 6,260 | 0 | 0 | $0 |
| Daniel Stanzione | 取締役 | 2020年11月23日 S | 28,349 | 0 | 0 | $0 |
| Jenne K Britell | 取締役 | 2018年6月4日 G | 14,479 | 0 | 0 | $0 |
| Jeffrey M Leiden | 取締役 | 2018年5月29日 S | 6,000 | 0 | 0 | $0 |
| John B Ziegler | 取締役 | 2017年2月22日 S | 16,557 | 0 | 0 | $0 |
| John C Baldwin MD | 取締役 | 2015年8月12日 S | 12,949 | 0 | 0 | $0 |
| William F Buehler | 取締役 | 2014年2月12日 M | 26,225 | 0 | 0 | $0 |
| GSK plc | 取締役 | 2011年1月31日 S | 0 | 0 | 0 | $0 |
| Rosanne Haggerty | 取締役 | 2010年5月6日 A | 9,334 | 0 | 0 | $0 |
| William R Grant | 取締役 | 2007年4月1日 A | 3,334 | 0 | 0 | $0 |
| James F Flaherty III | 取締役 | 2006年5月4日 A | 1,667 | 0 | 0 | $0 |
| Kenneth D Brody | 取締役 | 2004年4月28日 S | 0 | 0 | 0 | $0 |
| Mary A Cirillo | 取締役 | 2004年4月1日 A | 2,627 | 0 | 0 | $0 |
SECフォーム3/4/5提出書類からのインサイダー；純額＝公開市場のP/Sのみ
アクティビストおよび5%超のオーナー 13保有
SECスケジュール13Dを提出した投資家 — 発行体の影響を与える意図（アクティビストの保有、取締役会キャンペーン、M&A）を持つ5%超の受益権所有。各行は、その提出者のポジションの最新の既知の状態を示します。
| 提出者 | 提出済み | 保有 | ステータス | 目的 | 提出書類 |
|---|---|---|---|---|---|
| Quest Diagnostics Incorporated | 2011年5月18日 | — | 初回提出 | M&A / 売却 | SEC |
| 未開示の報告者 | 2011年2月1日 | — | 初回提出 | 受動的投資 | SEC |
| 未開示の報告者 | 2009年3月20日 | — | 初回提出 | — | SEC |
| GlaxoSmithKline plc ×2 提出書類 | 2008年9月18日 | — | 初回提出 | — | SEC |
| 未開示の報告者 | 2007年2月16日 | — | 初回提出 | — | SEC |
| Quest Diagnostics Incorporated - (FEIN No. ×2 提出書類 | 2006年1月19日 | — | 初回提出 | — | SEC |
| 未開示の報告者 | 2004年12月15日 | — | 初回提出 | — | SEC |
| 未開示の報告者 | 2004年6月29日 | — | 初回提出 | — | SEC |
| 未開示の報告者 | 2002年6月24日 | — | 初回提出 | M&A / 売却 | SEC |
| 未開示の報告者 | 2002年5月22日 | — | 初回提出 | — | SEC |
| 未開示の報告者 | 2002年4月12日 | — | 初回提出 | M&A / 売却 | SEC |
| IRS Identification Nos. of Above Persons (entities only) Quest Diagnostics Ventures LLC - (FEIN No., Quest Diagnostics Incorporated - (FEIN No. ×3 提出書類 | 2001年11月1日 | — | 初回提出 | M&A / 売却 | SEC |
| 未開示の報告者 | 2001年5月14日 | — | 初回提出 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF保有状況 183のETFが保有
ウェイトは直接株式保有（N-PORT）のみを反映しています。レバレッジ型またはデリバティブベースのファンドは、表示されていない追加のスワップエクスポージャーを保有している可能性があります。
| ファンド | ウェイト | 単位 | 時点 | ソース |
|---|---|---|---|---|
| IHF · iShares Trust | 3.91% | 203,179 SH | 2026年8月8日 | 日次 |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.77% | 58,107 SH | 2026年8月8日 | 日次 |
| FXH · First Trust Exchange-Traded AlphaDE… | 1.29% | 57,932 NS | 2026年4月30日 | N-PORT |
| CZA · Invesco Exchange-Traded Fund Trust | 1.22% | 9,813 SH | 2026年8月8日 | 日次 |
| TMFX · RBB Fund, Inc. | 1.05% | 1,724 NS | 2026年5月31日 | N-PORT |
| ANEW · ProShares Trust | 0.92% | 364 NS | 2026年5月31日 | N-PORT |
| QLTY · GMO ETF Trust | 0.85% | 196,208 NS | 2026年5月31日 | N-PORT |
| ALTL · Pacer Funds Trust | 0.82% | 4,047 NS | 2026年4月30日 | N-PORT |
| LSEQ · Harbor ETF Trust | 0.80% | 635 NS | 2026年4月30日 | N-PORT |
| SPVM · Invesco Exchange-Traded Fund Trust | 0.76% | 4,201 SH | 2026年8月8日 | 日次 |
| QLV · FlexShares Trust | 0.74% | 6,461 NS | 2026年4月30日 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 0.72% | 741 NS | 2026年5月31日 | N-PORT |
| ESMV · iShares Trust | 0.72% | 236 SH | 2026年8月8日 | 日次 |
| HUSV · First Trust Exchange-Traded Fund III | 0.52% | 1,956 NS | 2026年4月30日 | N-PORT |
| ITAN · EA Series Trust | 0.46% | 2,110 NS | 2026年5月29日 | N-PORT |
| QQWZ · Pacer Funds Trust | 0.44% | 1,055 NS | 2026年4月30日 | N-PORT |
| COWZ · Pacer Funds Trust | 0.44% | 409,814 NS | 2026年4月30日 | N-PORT |
| IYH · iShares Trust | 0.43% | 66,179 SH | 2026年8月8日 | 日次 |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0.41% | 3,999 NS | 2026年5月31日 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0.40% | 711,079 SH | 2026年8月8日 | 日次 |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.38% | 8,682 NS | 2026年4月30日 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.37% | 8,368 NS | 2026年4月30日 | N-PORT |
| IMCV · iShares Trust | 0.37% | 17,734 SH | 2026年8月8日 | 日次 |
| FHLC · FIDELITY COVINGTON TRUST | 0.35% | 51,278 NS | 2026年4月30日 | N-PORT |
| SUSA · iShares Trust | 0.35% | 60,308 SH | 2026年8月8日 | 日次 |
| FTA · First Trust Exchange-Traded AlphaDE… | 0.34% | 23,030 NS | 2026年4月30日 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.34% | 330,273 SH | 2026年8月8日 | 日次 |
| IXJ · iShares Trust | 0.33% | 58,047 SH | 2026年8月8日 | 日次 |
| RXL · ProShares Trust | 0.31% | 1,147 NS | 2026年5月31日 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0.31% | 2,194 NS | 2026年4月30日 | N-PORT |
| GNOM · Global X Funds | 0.28% | 789 NS | 2026年5月31日 | N-PORT |
| DFLV · Dimensional ETF Trust | 0.26% | 79,983 NS | 2026年4月30日 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0.26% | 7,703,000 | 2026年8月8日 | 日次 |
| IWS · iShares Trust | 0.25% | 166,611 SH | 2026年8月8日 | 日次 |
| FEX · First Trust Exchange-Traded AlphaDE… | 0.24% | 18,806 NS | 2026年4月30日 | N-PORT |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0.24% | 8,995 NS | 2026年4月30日 | N-PORT |
| EQIN · Columbia ETF Trust I | 0.23% | 3,340 NS | 2026年4月30日 | N-PORT |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0.23% | 26,229 NS | 2026年4月30日 | N-PORT |
| SIZE · iShares Trust | 0.23% | 4,242 SH | 2026年8月8日 | 日次 |
| VO · VANGUARD INDEX FUNDS | 0.23% | 2,398,948 SH | 2026年8月8日 | 日次 |
| BFOR · ALPS ETF Trust | 0.22% | 2,467 NS | 2026年5月31日 | N-PORT |
| EUSA · iShares, Inc. | 0.22% | 17,880 SH | 2026年8月8日 | 日次 |
| DFVE · DoubleLine ETF Trust | 0.22% | 307 NS | 2026年3月31日 | N-PORT |
| VFMV · VANGUARD WELLINGTON FUND | 0.22% | 4,307 SH | 2026年8月8日 | 日次 |
| RSP · Invesco Exchange-Traded Fund Trust | 0.22% | 910,753 SH | 2026年8月8日 | 日次 |
| GSEW · Goldman Sachs ETF Trust | 0.20% | 18,310 NS | 2026年5月31日 | N-PORT |
| ACWV · iShares, Inc. | 0.20% | 28,277 SH | 2026年8月8日 | 日次 |
| DEUS · DBX ETF Trust | 0.20% | 2,734 NS | 2026年5月29日 | N-PORT |
| IWR · iShares Trust | 0.19% | 449,590 SH | 2026年8月8日 | 日次 |
| IMCB · iShares Trust | 0.18% | 12,737 SH | 2026年8月8日 | 日次 |